EU | Updates to Regulation (EU) No 520/2012 — Key Pharmacovigilance Changes Applicable from 12 February 2026
Please login to view this page.
UK | MHRA Seeks Input on Regulation of AI in Healthcare at ‘Pivotal Moment’
Please login to view this page.
GLOBAL | ICH Concept Paper Endorsed for RWE Guideline on Medicines Effectiveness (ICH E23)
Please login to view this page.
EU | European Commission Proposes Health Innovation Package to Strengthen Biotech, Medical Devices and Cardiovascular Health
Please login to view this page.
EU | EMA and HMA Highlight Role of Alzheimer’s Disease Patient Registries in Addressing Evidence Gap
Please login to view this page.
EU | EMA Proposes Revision of Good Pharmacogenomic Practice Guideline to Reflect Scientific Advances
Please login to view this page.
EU | Editorial Highlights Growing Importance of Real-World Data in Pharmacovigilance and Regulatory Science
Please login to view this page.
USA | FDA Draft Guidance on Sex Differences Reinforces Expectations for Non-Interventional Studies
Please login to view this page.
- USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics Gallery
USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics
2025, December 2025, Members-Only, Moderate Update, RWD to Support Reg Decisions, Secondary Use of Existing Data, USA
USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics
Please login to view this page.










